Adenosine
Who holds supplier records for Adenosine? 6 organisations hold a current record for Adenosine: an active US FDA Type II Drug Master File or a CEP. A further 4 organisations have only historical (inactive) DMF filings. 4 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (2), China (2), Germany (1) and Italy (1).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Adenosine: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/adenosine
Reading the evidence
- 6 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 3 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (6)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Adenosine. Country is the organisation's recorded country, not necessarily the manufacturing site.
- Emcure Pharmaceuticals LimitedIndiaCEP Company GMP cert on recordActive DMF 33871 · latest filing May 2019
- PHARMA-WALDHOF GMBHGermanyCEPActive DMF 7728 · latest filing Oct 1988
- Wockhardt LimitedIndiaCEP Company GMP cert on recordActive DMF 20071 · latest filing May 2007
- Zhejiang Hisun Pharmaceutical Co., Ltd.ChinaCEP Company GMP cert on recordActive DMF 17306 · latest filing Apr 2004
- EUTICALS SPAItalyActive DMF 22232 · latest filing Nov 2008
- JOYANG LABORATORIESChinaActive DMF 40631 · latest filing Oct 2024
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (4)
Certificates of Suitability on the EDQM register for Adenosine, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| EMCURE PHARMACEUTICALS LIMITED Pune | IN | CEP 2023-079 - Rev 01 Adenosine | Jun 2026 | — |
| ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. Taizhou | CN | CEP 2013-044 - Rev 03 Adenosine | Apr 2026 | — |
| PHARMA WALDHOF GMBH Duesseldorf | DE | CEP 2025-070 - Rev 00 Adenosine | Nov 2025 | Inspected Feb 2026 Germany |
| Wockhardt Limited Mumbai | IN | R1-CEP 2008-258 - Rev 02 Adenosine | May 2022 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (4)
Organisations whose Type II DMFs for Adenosine are no longer active. These show a past filing, not current supply.
Show all 4 historical records
- Japan · Inactive DMF 17621 · filed Aug 2004
- United States · Inactive DMF 15900 · filed Mar 2002
- YAMASA SHOYU CO LTDInactive DMF 9777 · filed Jul 1992
- KYOWA HAKKO KOGYO CO LTDInactive DMF 8828 · filed Nov 1990
Overview
Adenosine is a nucleoside that plays a role in biochemical processes, such as energy transfer as adenosine triphosphate (ATP) and signal transduction as cyclic adenosine monophosphate (cAMP). It is also used as a medication to treat certain heart conditions and is known for its role in the biochemistry of sleep and apnea.
Chemical identity
- IUPAC name
- (2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
- Canonical SMILES
- C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)N
- InChIKey
- OIRDTQYFTABQOQ-KQYNXXCUSA-N
- Synonyms
- Adenocard API, adenosine, Adenocard, Adenoscan, Adenine riboside, Nucleocardyl, beta-D-Adenosine, Boniton, Sandesin, Myocol, Adenosin, beta-Adenosine
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Adenosine Receptor Agonist
- Mechanism of action
- Adenosine Receptor Agonists
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Adenosine?
6 organisations hold an active US FDA Type II Drug Master File or a CEP for Adenosine: Emcure Pharmaceuticals Limited (India), PHARMA-WALDHOF GMBH (Germany), Wockhardt Limited (India), Zhejiang Hisun Pharmaceutical Co., Ltd. (China), EUTICALS SPA (Italy) and JOYANG LABORATORIES (China). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Adenosine Drug Master Files are active?
Emcure Pharmaceuticals Limited (DMF 33871), PHARMA-WALDHOF GMBH (DMF 7728), Wockhardt Limited (DMF 20071), Zhejiang Hisun Pharmaceutical Co., Ltd. (DMF 17306), EUTICALS SPA (DMF 22232) and JOYANG LABORATORIES (DMF 40631). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Adenosine records mean?
4 organisations have only inactive Type II DMFs for Adenosine. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Adenosine have a European Certificate of Suitability?
Yes. 4 organisations hold a valid CEP for Adenosine on the EDQM register, including EMCURE PHARMACEUTICALS LIMITED Pune (IN), ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. Taizhou (CN), PHARMA WALDHOF GMBH Duesseldorf (DE) and Wockhardt Limited Mumbai (IN). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Adenosine supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Adenosine?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.